Helium Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-277
Closed -$212K 89
2025
Q3
$212K Sell
277
-341
-55% -$254K 0.18% 84
2025
Q2
$482K Sell
618
-70
-10% -$54.4K 0.3% 52
2025
Q1
$568K Hold
688
0.41% 43
2024
Q4
$531K Buy
+688
New +$570K 0.42% 45

Other funds holding LLY

Helium Advisors's LLY Position: Q4 2025 in Review

Helium Advisors sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 277 shares — an estimated $212K sold.

Helium Advisors first reported a position in LLY in Q4 2024 and held it in 4 quarters. The position peaked at $568K in Q1 2025. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Helium Advisors reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Helium Advisors sold 277 Eli Lilly shares in Q4 2025, an estimated $212K.
  • Helium Advisors first reported a position in Eli Lilly in Q4 2024 and held it in 4 quarters.
  • Helium Advisors's Eli Lilly position peaked at $568K in Q1 2025.
  • 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Helium Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.